Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Schmidt

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Biological Psychiatry|August 5, 2000
5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortexH Rollema, Y Lu, A W Schmidt, et al.
Microbiome|July 1, 2016
Variable responses of human microbiomes to dietary supplementation with resistant starchA Venkataraman, J R Sieber, A W Schmidt, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1989
The clinical utility of pharmacological agents that act at serotonin receptorsS J Peroutka, A J Sleight, B G McCarthy, et al.
Regulatory Peptides|July 2, 1993
CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptorS McLean, R M Snider, M C Desai, et al.
Journal of Medicinal Chemistry|October 1, 1991
Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compoundsB L Chenard, I A Shalaby, B K Koe, et al.
Journal of Medicinal Chemistry|November 13, 1992
Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotoninJ E Macor, J Blake, C B Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2011
Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptorsS Grimwood, Y Lu, A W Schmidt, et al.
Journal of Medicinal Chemistry|August 5, 1994
5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivityJ E Macor, D H Blank, C B Fox, et al.
Journal of Medicinal Chemistry|June 1, 1991
1-Naphthylpiperazine derivatives as potential atypical antipsychotic agentsJ A Lowe, T F Seeger, A A Nagel, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|August 5, 2000
5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortexH Rollema, Y Lu, A W Schmidt, et al.
Microbiome|July 1, 2016
Variable responses of human microbiomes to dietary supplementation with resistant starchA Venkataraman, J R Sieber, A W Schmidt, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1989
The clinical utility of pharmacological agents that act at serotonin receptorsS J Peroutka, A J Sleight, B G McCarthy, et al.
Regulatory Peptides|July 2, 1993
CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptorS McLean, R M Snider, M C Desai, et al.
Journal of Medicinal Chemistry|October 1, 1991
Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compoundsB L Chenard, I A Shalaby, B K Koe, et al.
Journal of Medicinal Chemistry|November 13, 1992
Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotoninJ E Macor, J Blake, C B Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2011
Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptorsS Grimwood, Y Lu, A W Schmidt, et al.
Journal of Medicinal Chemistry|August 5, 1994
5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivityJ E Macor, D H Blank, C B Fox, et al.
Journal of Medicinal Chemistry|June 1, 1991
1-Naphthylpiperazine derivatives as potential atypical antipsychotic agentsJ A Lowe, T F Seeger, A A Nagel, et al.
Pageof 4